Stately Bio
6 known investors
Stately Bio develops stem cell-derived regenerative and cell therapies using a machine learning platform that measures cell identity, behavior, and maturation directly from live-cell, label-free imaging. It partners with institutions and companies in the cell therapy field to support therapy discovery and manufacturing.
AI & Machine LearningBiotechMedical Devices
Investors · 6
Frequently asked questions
- What does Stately Bio do?
- Stately Bio develops stem cell-derived regenerative and cell therapies using a machine learning platform that measures cell identity, behavior, and maturation directly from live-cell, label-free imaging. It partners with institutions and companies in the cell therapy field to support therapy discovery and manufacturing.
- Who are Stately Bio's investors?
- Stately Bio's investors include AIX Ventures, Foothill Ventures, Mitsui Global Investment, Axial VC, BoxOne Ventures, Dimension Capital.